AAAAAA

   
Results: 1-25 | 26-28
Results: 1-25/28
Endocannabinoids control spasticity in a multiple sclerosis model
Authors: Baker, D Pryce, G Croxford, JL Brown, P Pertwee, RG Makriyannis, A Khanolkar, A Layward, L Fezza, F Bisogno, T Di Marzo, V
Citation: D. Baker et al., Endocannabinoids control spasticity in a multiple sclerosis model, FASEB J, 15(2), 2001, pp. 300-302
Cannabinoid receptors and pain
Authors: Pertwee, RG
Citation: Rg. Pertwee, Cannabinoid receptors and pain, PROG NEUROB, 63(5), 2001, pp. 569-611
Agonist-induced internalization and trafficking of cannabinoid CB1 receptors in hippocampal neurons
Authors: Coutts, AA Anavi-Goffer, S Ross, RA MacEwan, DJ Mackie, K Pertwee, RG Irving, AJ
Citation: Aa. Coutts et al., Agonist-induced internalization and trafficking of cannabinoid CB1 receptors in hippocampal neurons, J NEUROSC, 21(7), 2001, pp. 2425-2433
Actions of cannabinoid receptor ligands on rat cultured sensory neurones: implications for antinociception
Authors: Ross, RA Coutts, AA McFarlane, SM Anavi-Goffer, S Irving, AJ Pertwee, RG MacEwan, DJ Scott, RH
Citation: Ra. Ross et al., Actions of cannabinoid receptor ligands on rat cultured sensory neurones: implications for antinociception, NEUROPHARM, 40(2), 2001, pp. 221-232
Cannabinoids and the gastrointestinal tract
Authors: Pertwee, RG
Citation: Rg. Pertwee, Cannabinoids and the gastrointestinal tract, GUT, 48(6), 2001, pp. 859-867
A possible role of lipoxygenase in the activation of vanilloid receptors by anandamide in the guinea-pig bronchus
Authors: Craib, SJ Ellington, HC Pertwee, RG Ross, RA
Citation: Sj. Craib et al., A possible role of lipoxygenase in the activation of vanilloid receptors by anandamide in the guinea-pig bronchus, BR J PHARM, 134(1), 2001, pp. 30-37
Structure-activity relationship for the endogenous cannabinoid, anandamide, and certain of its analogues at vanilloid receptors in transfected cells and vas deferens
Authors: Ross, RA Gibson, TM Brockie, HC Leslie, M Pashmi, G Craib, SJ Di Marzo, V Pertwee, RG
Citation: Ra. Ross et al., Structure-activity relationship for the endogenous cannabinoid, anandamide, and certain of its analogues at vanilloid receptors in transfected cells and vas deferens, BR J PHARM, 132(3), 2001, pp. 631-640
Pharmacological actions and therapeutic uses of cannabis and cannabinoids
Authors: Kumar, RN Chambers, WA Pertwee, RG
Citation: Rn. Kumar et al., Pharmacological actions and therapeutic uses of cannabis and cannabinoids, ANAESTHESIA, 56(11), 2001, pp. 1059-1068
Neuropharmacology and therapeutic potential of cannabinoids
Authors: Pertwee, RG
Citation: Rg. Pertwee, Neuropharmacology and therapeutic potential of cannabinoids, ADDICT BIOL, 5(1), 2000, pp. 37-46
Cannabinoid receptor ligands: clinical and neuropharmacological considerations, relevant to future drug discovery and development
Authors: Pertwee, RG
Citation: Rg. Pertwee, Cannabinoid receptor ligands: clinical and neuropharmacological considerations, relevant to future drug discovery and development, EXPERT OP I, 9(7), 2000, pp. 1553-1571
Functional expression of cell surface cannabinoid CB1 receptors on presynaptic inhibitory terminals in cultured rat hippocampal neurons
Authors: Irving, AJ Coutts, AA Harvey, J Rae, MG Mackie, K Bewick, GS Pertwee, RG
Citation: Aj. Irving et al., Functional expression of cell surface cannabinoid CB1 receptors on presynaptic inhibitory terminals in cultured rat hippocampal neurons, NEUROSCIENC, 98(2), 2000, pp. 253-262
Cannabinoids control spasticity and tremor in a multiple sclerosis model
Authors: Baker, D Pryce, G Croxford, JL Brown, P Pertwee, RG Huffman, JW Layward, L
Citation: D. Baker et al., Cannabinoids control spasticity and tremor in a multiple sclerosis model, NATURE, 404(6773), 2000, pp. 84-87
Overlap between the ligand recognition properties of the anandamide transporter and the VR1 vanilloid receptor: inhibitors of anandamide uptake with negligible capsaicin-like activity
Authors: De Petrocellis, L Bisogno, T Davis, JB Pertwee, RG Di Marzo, V
Citation: L. De Petrocellis et al., Overlap between the ligand recognition properties of the anandamide transporter and the VR1 vanilloid receptor: inhibitors of anandamide uptake with negligible capsaicin-like activity, FEBS LETTER, 483(1), 2000, pp. 52-56
Inhibition of nitric oxide production in RAW264.7 macrophages by cannabinoids and palmitoylethanolamide
Authors: Ross, RA Brockie, HC Pertwee, RG
Citation: Ra. Ross et al., Inhibition of nitric oxide production in RAW264.7 macrophages by cannabinoids and palmitoylethanolamide, EUR J PHARM, 401(2), 2000, pp. 121-130
O-1057, a potent water-soluble cannabinoid receptor agonist with antinociceptive properties
Authors: Pertwee, RG Gibson, TM Stevenson, LA Ross, RA Banner, WK Saha, B Razdan, RK Martin, BR
Citation: Rg. Pertwee et al., O-1057, a potent water-soluble cannabinoid receptor agonist with antinociceptive properties, BR J PHARM, 129(8), 2000, pp. 1577-1584
Comparison of novel cannabinoid partial agonists and SR141716A in the guinea-pig small intestine
Authors: Coutts, AA Brewster, N Ingram, T Razdan, RK Pertwee, RG
Citation: Aa. Coutts et al., Comparison of novel cannabinoid partial agonists and SR141716A in the guinea-pig small intestine, BR J PHARM, 129(4), 2000, pp. 645-652
Prescribing cannabinoids for multiple sclerosis - Current issues
Authors: Pertwee, RG
Citation: Rg. Pertwee, Prescribing cannabinoids for multiple sclerosis - Current issues, CNS DRUGS, 11(5), 1999, pp. 327-334
Cannabis and cannabinoids: Pharmacology and rationale for clinical use
Authors: Pertwee, RG
Citation: Rg. Pertwee, Cannabis and cannabinoids: Pharmacology and rationale for clinical use, FORSCH KOMP, 6, 1999, pp. 12-15
Medical uses of cannabinoids: the way forward
Authors: Pertwee, RG
Citation: Rg. Pertwee, Medical uses of cannabinoids: the way forward, ADDICTION, 94(3), 1999, pp. 317-320
Pharmacology of cannabinoid receptor ligands
Authors: Pertwee, RG
Citation: Rg. Pertwee, Pharmacology of cannabinoid receptor ligands, CURR MED CH, 6(8), 1999, pp. 635-664
Development of agonists, partial agonists and antagonists in the Delta(8)-tetrahydrocannabinol series
Authors: Crocker, PJ Saha, B Ryan, WJ Wiley, JL Martin, BR Ross, RA Pertwee, RG Razdan, RK
Citation: Pj. Crocker et al., Development of agonists, partial agonists and antagonists in the Delta(8)-tetrahydrocannabinol series, TETRAHEDRON, 55(49), 1999, pp. 13907-13926
HU-308: A specific agonist for CB2, a peripheral cannabinoid receptor
Authors: Hanus, L Breuer, A Tchilibon, S Shiloah, S Goldenberg, D Horowitz, M Pertwee, RG Ross, RA Mechoulam, R Fride, E
Citation: L. Hanus et al., HU-308: A specific agonist for CB2, a peripheral cannabinoid receptor, P NAS US, 96(25), 1999, pp. 14228-14233
Evidence for the presence of CB1 cannabinoid receptors on peripheral neurones and for the existence of neuronal non-CB1 cannabinoid receptors
Authors: Pertwee, RG
Citation: Rg. Pertwee, Evidence for the presence of CB1 cannabinoid receptors on peripheral neurones and for the existence of neuronal non-CB1 cannabinoid receptors, LIFE SCI, 65(6-7), 1999, pp. 597-605
Synthesis and characterization of potent and selective agonists of the neuronal cannabinoid receptor (CB1)
Authors: Hillard, CJ Manna, S Greenberg, MJ Dicamelli, R Ross, RA Stevenson, LA Murphy, V Pertwee, RG Campbell, WB
Citation: Cj. Hillard et al., Synthesis and characterization of potent and selective agonists of the neuronal cannabinoid receptor (CB1), J PHARM EXP, 289(3), 1999, pp. 1427-1433
Structural determinants of the partial agonist-inverse agonist properties of 6 '-azidohex-2 '-yne-Delta(8)-tetrahydrocannabinol at cannabinoid receptors
Authors: Ross, RA Gibson, TM Stevenson, LA Saha, B Crocker, P Razdan, RK Pertwee, RG
Citation: Ra. Ross et al., Structural determinants of the partial agonist-inverse agonist properties of 6 '-azidohex-2 '-yne-Delta(8)-tetrahydrocannabinol at cannabinoid receptors, BR J PHARM, 128(3), 1999, pp. 735-743
Risultati: 1-25 | 26-28